Archive for November 2008

November 17, 2008

LICR Research Leads to US Pharmaceutical Licensing Deal

The international Ludwig Institute for Cancer Research (LICR) announced today that one of its spin-off companies, Life Science Pharmaceuticals, has licensed its lead cancer therapy candidate to pharmaceutical company Abbott.

More »


Search the LICR News Archives

You are currently browsing the LICR News Archive for November 2008.

Browse The LICR News Archives